ABT spinoff factoids re The Global Demographic Tailwind:
• The diversified products successor company (the one that will continue to be called Abbott) will derive 47% of sales from emerging markets in 2014, up from 39% currently.
• ABT’s nutritionals business, which comprises about a quarter of the diversified products successor company, will have $1B of sales in China alone by 2014.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.